Artificial Intelligence in Healthcare: What It Can Do, What It Can’t, and What Patients Should Know

| | |

Artificial intelligence is increasingly used in U.S. healthcare, from reading scans to drafting medical notes. Here’s what the evidence shows, where human judgment still matters most, and what patients should understand.

Artificial intelligence (AI) is now part of everyday healthcare in the United States. It helps read X-rays, flag abnormal heart rhythms, draft clinic notes, and even answer patient questions online. But AI is a tool—not a doctor. Understanding what it can and cannot do can help patients and families make informed decisions.

Here’s what the evidence shows so far, where AI appears most useful, and what still depends on human judgment.

Where AI Is Already Showing Up

Many people interact with AI in healthcare without realizing it.

  • Medical imaging: AI programs can help detect lung nodules on CT scans, diabetic eye disease on retinal photos, and certain skin lesions. The U.S. Food and Drug Administration (FDA) has cleared hundreds of AI-enabled medical devices, most in radiology.
  • Heart rhythm monitoring: Some wearable devices use algorithms to flag irregular heart rhythms such as atrial fibrillation. These alerts are screening tools and still require medical confirmation.
  • Clinical documentation: So-called “ambient AI” tools can draft visit notes for clinicians, potentially reducing paperwork time.
  • Hospital safety alerts: AI systems may flag early signs of sepsis or medication interactions based on patterns in electronic health records.

According to the FDA’s Digital Health Center of Excellence, AI-based software used for medical purposes must meet regulatory standards similar to other medical devices. That includes evidence of safety and effectiveness for specific uses.

What the Research Actually Shows

Much of the strongest evidence for AI in healthcare comes from diagnostic support, especially in imaging.

For example, randomized trials and real-world studies published in journals such as JAMA Network and The Lancet have found that AI-assisted colonoscopy can increase detection of small polyps. Other studies show that autonomous AI systems can screen for diabetic retinopathy in primary care settings with accuracy comparable to specialists when used as intended.

However, most AI studies focus on narrow tasks in controlled settings. Many are observational studies, meaning they look at outcomes after AI is introduced rather than randomly assigning patients. That makes it harder to know how much improvement is directly caused by the AI tool itself.

Common limitations include:

  • Testing in a single hospital system
  • Limited diversity in patient populations
  • Short follow-up periods
  • Performance measured under ideal conditions rather than everyday practice

The National Institutes of Health (NIH) and the World Health Organization (WHO) have both emphasized that AI tools require ongoing monitoring after deployment to ensure they continue to perform safely across different populations.

Where Human Clinicians Still Lead

AI is strongest at recognizing patterns in large amounts of data. It is not designed to replace the broader judgment of a trained clinician.

Doctors, nurses, and other healthcare professionals integrate:

  • A patient’s medical history
  • Family and social context
  • Personal goals and values
  • Subtle physical exam findings
  • Ethical and legal considerations

Complex decisions—such as whether to start chemotherapy, how to manage multiple chronic conditions, or how to weigh risks and benefits of surgery—depend heavily on human conversation and shared decision-making.

Concerns About Bias and Accuracy

One important issue in AI research is bias. If an algorithm is trained mostly on data from certain age groups, racial backgrounds, or hospital systems, it may not perform as well for others.

Researchers have documented cases where prediction models underestimated risk in certain populations. Agencies such as the FDA, NIH, and professional organizations including the American Medical Association have called for greater transparency about how AI tools are developed and tested.

Patients should understand that no screening test—human or AI—is perfect. False positives (incorrect alerts) and false negatives (missed conditions) can happen.

What This Means for Everyday Patients

If AI is used in your care, you may not always be told explicitly. In many cases, it functions as background decision support.

It is reasonable to ask your clinician:

  • Whether an AI tool was used in interpreting a test
  • How accurate it is for someone like you
  • What happens if the AI and clinician disagree
  • How your health data are protected

Under U.S. privacy laws such as HIPAA, healthcare providers must protect patient health information. However, consumer health apps and wearables may operate under different privacy standards. Always review app permissions and data-sharing policies.

Costs, Access, and Health Equity

AI has the potential to expand access in underserved areas, especially for screening tasks like diabetic eye exams or remote heart monitoring. But access depends on reliable internet, follow-up care availability, and insurance coverage.

Medicare and private insurers may cover AI-assisted procedures if they are part of an approved diagnostic service. Coverage varies, and patients should check with their insurance provider for specific details.

There is also concern that unequal access to digital tools could widen health disparities if certain communities benefit more than others. Public health experts stress the importance of monitoring how new technologies affect different populations.

When to Seek Medical Care

AI tools—especially symptom checkers and wearable alerts—should not replace urgent medical evaluation.

Seek immediate care or call emergency services if you experience:

  • Chest pain
  • Severe shortness of breath
  • Signs of stroke (face drooping, arm weakness, speech difficulty)
  • Sudden confusion or fainting

Use AI-powered tools as informational aids, not final medical decisions.

What’s Still Uncertain

AI in healthcare is evolving rapidly. Open questions include:

  • How well tools perform over years in real-world settings
  • How to best monitor algorithms for drift or changing accuracy
  • How to ensure fairness across racial, age, and socioeconomic groups
  • How liability is handled when errors occur

Federal agencies, academic researchers, and professional organizations are actively studying these issues.

The Bottom Line

Artificial intelligence is becoming a routine part of U.S. healthcare—but it works best as an assistive tool. It can help detect patterns, streamline workflows, and expand screening access. It does not replace human judgment, conversation, or accountability.

For patients and families, the practical takeaway is simple: Ask questions, understand how tools are used in your care, and remember that final decisions still belong to you and your healthcare team.

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.

Sources

  • U.S. Food and Drug Administration (FDA) – Digital Health Center of Excellence
  • National Institutes of Health (NIH)
  • World Health Organization (WHO) – Ethics and Governance of Artificial Intelligence for Health
  • JAMA Network
  • The Lancet

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.